Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New glaucoma surgery under the microscope: 300 patients tracked for 2 years

NCT ID NCT05506423

Disease control Sponsor: Iantrek, Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 23, 2026 · Updated 3 times

Summary

This study follows 300 adults with open-angle glaucoma who had a surgery called CycloPen™ to lower eye pressure. Researchers will check if the surgery safely reduces eye pressure by at least 20% and if patients need fewer eye drops over 24 months. The goal is to see how well this procedure controls the disease long-term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 300 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2022

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Eligible participants who underwent IOP-lowering surgical procedures using the CycloPen Micro-Interventional System for uveoscleral outflow enhancement

Ages

21 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

To be included, participants must have: 1. Open angle glaucoma 2. IOP-lowering surgical procedure using the CycloPen System There are no exclusionary criteria.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Open angle glaucoma are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

open-angle glaucoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Open angle glaucoma

Contacts and locations

Locations

  • Buffalo Ophthalmology

    Williamsville, New York, 14221, United States

  • Center for Sight

    Las Vegas, Nevada, 89145, United States

  • Central Florida Eye Specialists

    DeLand, Florida, 32720, United States

  • Eye Associates of Ft. Myers

    Fort Myers, Florida, 33912, United States

  • Eye Centers of Tennessee

    Crossville, Tennessee, 38555, United States

  • Eye Doctors of Washington

    Chevy Chase, Maryland, 20815, United States

  • James S Lewis, MD

    Fort Washington, Pennsylvania, 19034, United States

  • John Moran Eye Center - U of Utah

    Salt Lake City, Utah, 84132, United States

  • North Manhattan Eye Center

    New York, New York, 10034, United States

  • Omni Eye Services

    Atlanta, Georgia, 30342, United States

  • Ophthalmology Associates

    Fort Worth, Texas, 76102, United States

  • Panama Eye Center

    Panama City, Panama

  • Tyson Eye

    Cape Coral, Florida, 33904, United States

  • Visionary Eye Doctors

    Rockville, Maryland, 20852, United States

  • Visionary Eye Institute

    Newport Beach, California, 92663, United States

  • Wilton Center for Advanced Eyecare

    New Brunswick, New Jersey, 07728, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.